Pediatric Radiology

, Volume 41, Issue 9, pp 1183–1197

Characterization of pediatric liver lesions with gadoxetate disodium

  • Arthur B. Meyers
  • Alexander J. Towbin
  • Suraj Serai
  • James I. Geller
  • Daniel J. Podberesky
Pictorial Essay


Gadoxetate disodium (Gd-EOB-DTPA) is a relatively new hepatobiliary MRI contrast agent. It is increasingly used in adults to characterize hepatic masses, but there is little published describing its use in children. The purpose of this paper is to describe our pediatric MRI protocol as well as the imaging appearance of pediatric liver lesions using gadoxetate disodium. As a hepatocyte-specific MRI contrast agent, Gd-EOB-DTPA has the potential to improve characterization and provide a more specific diagnosis of pediatric liver masses.


Pediatric liver tumors Pediatric liver MRI Gadoxetate disodium 


  1. 1.
    Ringe KI, Husarik DB, Sirlin CB et al (2010) Gadoxetate disodium-enhanced MRI of the liver: part 1, protocol optimization and lesion appearance in the noncirrhotic liver. AJR 195:13–28PubMedCrossRefGoogle Scholar
  2. 2.
    Cruite I, Schroeder M, Merkle EM et al (2010) Gadoxetate disodium-enhanced MRI of the liver: part 2, protocol optimization and lesion appearance in the cirrhotic liver. AJR 195:29–41PubMedCrossRefGoogle Scholar
  3. 3.
    Joyner BL Jr, Levin TL, Goyal RK et al (2005) Focal nodular hyperplasia of the liver: a sequela of tumor therapy. Pediatr Radiol 35:1234–1239PubMedCrossRefGoogle Scholar
  4. 4.
    Towbin AJ, Luo GG, Yin H et al (2010) Focal nodular hyperplasia in children, adolescents, and young adults. Pediatr Radiol 41:341–349PubMedCrossRefGoogle Scholar
  5. 5.
    Vasanawala S (2010) MRI of the liver—how to do it. Pediatr Radiol 40:431–437PubMedCrossRefGoogle Scholar
  6. 6.
    Marrone G, Maggiore G, Carollo V et al (2011) Biliary cystadenoma with bile duct communication depicted on liver-specific contrast agent-enhanced MRI in a child. Pediatr Radiol 41:121–124PubMedCrossRefGoogle Scholar
  7. 7.
    Raman S, Leary C, Bluemke D et al (2010) Improved characterization of focal liver lesions with liver-specific gadoxetic acid disodium-enhanced magnetic resonance imaging: a multicenter phase 2 clinical trial. J Comput Assist Tomogr 34:163–172PubMedCrossRefGoogle Scholar
  8. 8.
    Reimer P, Rummeny EJ, Shamsi K et al (1996) Phase II clinical evaluation of Gd-EOB-DTPA: dose, safety aspects, and pulse sequence. Radiology 199:177–183PubMedGoogle Scholar
  9. 9.
    Jimenez RM, Connolly S, Blickman JG (2008) Accessory organs of digestion. In: Devos AS, Blickman JG (eds) Radiologic imaging of the digestive tract in infants and children. Springer, New York, pp 133–165CrossRefGoogle Scholar
  10. 10.
    Das CJ, Dhingra S, Gupta AK et al (2009) Imaging of paediatric liver tumours with pathological correlation. Clin Radiol 64:1015–1025PubMedCrossRefGoogle Scholar
  11. 11.
    Imbach P (2006) Hepatic tumors. In: Imbach P, Kuhne T, Arceci RJ (eds) Pediatric oncology: a comprehensive guide. Springer, New York, pp 187–191CrossRefGoogle Scholar
  12. 12.
    Prokurat A, Kluge P, Kosciesza A et al (2002) Transitional liver cell tumors (TLCT) in older children and adolescents: a novel group of aggressive hepatic tumors expressing beta-catenin. Med Pediatr Oncol 39:510–518PubMedCrossRefGoogle Scholar
  13. 13.
    Moore CW, Lowe LH (2008) Hepatic tumors and tumor-like conditions. In: Slovis TL (ed) Caffey’s pediatric radiology, 11th edn. Mosby, Philadelphia, pp 1929–1948Google Scholar
  14. 14.
    Crider MH, Hoggard E, Manivel JC (2009) Undifferentiated (embryonal) sarcoma of the liver. Radiographics 29:1665–1668PubMedCrossRefGoogle Scholar
  15. 15.
    Kim M, Tireno B, Slanetz PJ (2008) Undifferentiated embryonal sarcoma of the liver. AJR 190:W261–W262PubMedCrossRefGoogle Scholar
  16. 16.
    Braga L, Armao D, Semelka RC (2006) Liver. In: Semelka RC (ed) Abdominal-pelvic MRI, 2nd edn. Wiley, Hoboken, pp 47–447Google Scholar
  17. 17.
    Chung EM, Cube R, Lewis RB et al (2010) From the archives of the AFIP. Pediatric liver masses: radiologic-pathologic correlation part 1. Benign tumors. Radiographics 30:801–826PubMedCrossRefGoogle Scholar
  18. 18.
    Christison-Lagay ER, Burrows PE, Alomari A et al (2007) Hepatic hemangiomas: subtype classification and development of a clinical practice algorithm and registry. J Pediatr Surg 42:62–67PubMedCrossRefGoogle Scholar
  19. 19.
    Goshima S, Kanematsu M, Watanabe H et al (2010) Hepatic hemangioma and metastasis: differentiation with gadoxetate disodium-enhanced 3-T MRI. AJR 195:941–946PubMedCrossRefGoogle Scholar
  20. 20.
    Karam AR, Shankar S, Surapaneni P et al (2010) Focal nodular hyperplasia: central scar enhancement pattern using gadoxetate disodium. J Magn Reson Imaging 32:341–344PubMedCrossRefGoogle Scholar
  21. 21.
    Zech CJ, Herrmann KA, Reiser MF et al (2007) MR imaging in patients with suspected liver metastases: value of liver-specific contrast agent Gd-EOB-DTPA. Magn Reson Med Sci 6:43–52PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2011

Authors and Affiliations

  • Arthur B. Meyers
    • 1
  • Alexander J. Towbin
    • 1
  • Suraj Serai
    • 1
  • James I. Geller
    • 2
  • Daniel J. Podberesky
    • 1
  1. 1.Department of Radiology, MLC 5031Cincinnati Children’s Hospital Medical CenterCincinnatiUSA
  2. 2.Department of Hematology-OncologyCincinnati Children’s Hospital Medical CenterCincinnatiUSA

Personalised recommendations